Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

This publication has 20 references indexed in Scilit:

• Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.
  Journal of Clinical Oncology, 1996
• CPT-11 (Irinotecan) in the treatment of colorectal cancer
  European Journal Of Cancer, 1995
• Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma
  Annals of Oncology, 1994
• Topoisomerase I inhibitors: topotecan and irenotecan
  Cancer Treatment Reviews, 1994
• Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.
  BMJ, 1993
• The chemotherapy of colon cancer can no longer be ignored
  European Journal Of Cancer, 1993
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1992
• Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.
  Journal of Clinical Oncology, 1992
• Protracted Infusion of 5-FU with Weekly Low-Dose Cisplatin as Second-Line Therapy in Patients with Metastatic Colorectal Cancer Who Have Failed 5-FU Monotherapy
  Cancer Investigation, 1991
• Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer
  Cancer, 1989